IAIM
CYTK icon

International Assets Investment Management’s Cytokinetics CYTK Stock Holding History

International Assets Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,560
Closed -$200 – 1061
2024
Q3 		$200 Buy
+10,560
New +$589K ﹤0.01% 1535

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

International Assets Investment Management's CYTK Position: Q4 2024 in Review

International Assets Investment Management sold out of Cytokinetics (CYTK) in Q4 2024, closing a stake of 10,560 shares — an estimated $200 sold.

International Assets Investment Management first reported a position in CYTK in Q3 2024 and held it in 1 quarter. The position peaked at $200 in Q3 2024. 346 funds tracked by Wall St. Rank hold CYTK as of Q4 2024.

  • International Assets Investment Management reported no remaining Cytokinetics position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 10,560 Cytokinetics shares in Q4 2024, an estimated $200.
  • International Assets Investment Management first reported a position in Cytokinetics in Q3 2024 and held it in 1 quarter.
  • International Assets Investment Management's Cytokinetics position peaked at $200 in Q3 2024.
  • 346 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.